At the time of writing, Elevance Health Inc [ELV] stock is trading at $338.52, up 0.67%. An important factor to consider is whether the stock is rising or falling in short-term value. The ELV shares have gain 7.00% over the last week, with a monthly amount drifted -0.26%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Argus downgraded its rating to Hold on July 21, 2025. On July 18, 2025, downgrade downgraded it’s rating to Market Perform but maintained its price target of $310 on the stock. Robert W. Baird downgraded its rating to a Neutral but stick to its price target of $529 on April 15, 2025. Argus upgraded its rating to a Buy but $450 remained the price target by the analyst firm on March 17, 2025. Stephens downgraded its rating to Equal-Weight for this stock on January 22, 2025, and downed its price target to $440. In a note dated October 18, 2024, Argus downgraded a Hold rating on this stock.
For the past year, the stock price of Elevance Health Inc fluctuated between $273.71 and $458.75. Currently, Wall Street analysts expect the stock to reach $389.63 within the next 12 months. Elevance Health Inc [NYSE: ELV] shares were valued at $338.52 at the most recent close of the market. An investor can expect a potential return of 15.1% based on the average ELV price forecast.
Analyzing the ELV fundamentals
According to Elevance Health Inc [NYSE:ELV], the company’s sales were 194.82B for trailing twelve months, which represents an 12.33% jump. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.04%, Pretax Profit Margin comes in at 0.04%, and Net Profit Margin reading is 0.03%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.13 and Total Capital is 0.09. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 333.19 points at the first support level, and at 327.86 for the second support level. However, for the 1st resistance point, the stock is sitting at 342.87, and for the 2nd resistance point, it is at 347.22.
Ratios To Look Out For
It is important to note that Elevance Health Inc [NYSE:ELV] has a current ratio of 1.56. Considering the valuation of this stock, the price to sales ratio is 0.39, the price to book ratio is 1.71 and price to earnings (TTM) ratio is 13.84.
Transactions by insiders
Recent insider trading involved DeVore Susan D., Director, that happened on Aug 19 ’25 when 1200.0 shares were purchased. President and CEO, BOUDREAUX GAIL completed a deal on Jul 18 ’25 to buy 8500.0 shares. Meanwhile, EVP & CFO Kaye Mark sold 4588.0 shares on Apr 24 ’25.
